Intrinsic Value of S&P & Nasdaq Contact Us

AVROBIO, Inc. AVRO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — AVRO

AVROBIO, Inc. (AVRO) has a market capitalization of $5.24M and trades at $1.40. The 52-week range is 1.38-19.8.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-4.05.

The stock has a beta of 1.22, operates in the Healthcare sector.

Trading Data
Current Price$1.40
52-Week Range1.38-19.8
Volume204.38K
Avg Volume (30D)19.05K
Market Cap$5.24M
Beta (1Y)1.22
Company
IPO Date2018-06-21
Employees13
CEOErik John Ostrowski
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS05455M1009
CUSIP05455M100
Income (Latest Year)
EBITDA$-71.48M
Operating Income$-84.04M
Net Income$-74.15M
EPS$-4.05
EPS Diluted$-4.05
Shares Outstanding$18.32M
Balance Sheet (Latest Year)
Total Assets$261.04M
Current Assets$257.36M
Cash & ST Investments$253.8M
Total Liabilities$9.71M
Total Debt$1.28M
Net Debt$-252.52M
Total Equity$251.33M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-0.3
P/B Ratio0.02
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message